Lung transplantation

Chronic allograft dysfunction and establishing immune tolerance

Adam S A Gracon, David S. Wilkes

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Despite significant medical advances since the advent of lung transplantation, improvements in long-term survival have been largely unrealized. Chronic lung allograft dysfunction, in particular obliterative bronchiolitis, is the primary limiting factor. The predominant etiology of obliterative bronchiolitis involves the recipient's innate and adaptive immune response to the transplanted allograft. Current therapeutic strategies have failed to provide a definitive treatment paradigm to improve long-term outcomes. Inducing immune tolerance is an emerging therapeutic strategy that abrogates allograft rejection, avoids immunosuppression, and improves long-term graft function. The aim of this review is to discuss the key immunologic components of obliterative bronchiolitis, describe the state of establishing immune tolerance in transplantation, and highlight those strategies being evaluated in lung transplantation.

Original languageEnglish
Pages (from-to)887-894
Number of pages8
JournalHuman Immunology
Volume75
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Immune Tolerance
Bronchiolitis
Lung Transplantation
Allografts
Adaptive Immunity
Innate Immunity
Immunosuppression
Therapeutics
Transplantation
Transplants
Lung

Keywords

  • Chronic lung allograft dysfunction
  • Immune tolerance
  • Obliterative bronchiolitis
  • Transplant immunology
  • Transplant tolerance

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Lung transplantation : Chronic allograft dysfunction and establishing immune tolerance. / Gracon, Adam S A; Wilkes, David S.

In: Human Immunology, Vol. 75, No. 8, 2014, p. 887-894.

Research output: Contribution to journalArticle

Gracon, Adam S A ; Wilkes, David S. / Lung transplantation : Chronic allograft dysfunction and establishing immune tolerance. In: Human Immunology. 2014 ; Vol. 75, No. 8. pp. 887-894.
@article{19335192e29d4ed99d63c8b45499c72c,
title = "Lung transplantation: Chronic allograft dysfunction and establishing immune tolerance",
abstract = "Despite significant medical advances since the advent of lung transplantation, improvements in long-term survival have been largely unrealized. Chronic lung allograft dysfunction, in particular obliterative bronchiolitis, is the primary limiting factor. The predominant etiology of obliterative bronchiolitis involves the recipient's innate and adaptive immune response to the transplanted allograft. Current therapeutic strategies have failed to provide a definitive treatment paradigm to improve long-term outcomes. Inducing immune tolerance is an emerging therapeutic strategy that abrogates allograft rejection, avoids immunosuppression, and improves long-term graft function. The aim of this review is to discuss the key immunologic components of obliterative bronchiolitis, describe the state of establishing immune tolerance in transplantation, and highlight those strategies being evaluated in lung transplantation.",
keywords = "Chronic lung allograft dysfunction, Immune tolerance, Obliterative bronchiolitis, Transplant immunology, Transplant tolerance",
author = "Gracon, {Adam S A} and Wilkes, {David S.}",
year = "2014",
doi = "10.1016/j.humimm.2014.06.015",
language = "English",
volume = "75",
pages = "887--894",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Lung transplantation

T2 - Chronic allograft dysfunction and establishing immune tolerance

AU - Gracon, Adam S A

AU - Wilkes, David S.

PY - 2014

Y1 - 2014

N2 - Despite significant medical advances since the advent of lung transplantation, improvements in long-term survival have been largely unrealized. Chronic lung allograft dysfunction, in particular obliterative bronchiolitis, is the primary limiting factor. The predominant etiology of obliterative bronchiolitis involves the recipient's innate and adaptive immune response to the transplanted allograft. Current therapeutic strategies have failed to provide a definitive treatment paradigm to improve long-term outcomes. Inducing immune tolerance is an emerging therapeutic strategy that abrogates allograft rejection, avoids immunosuppression, and improves long-term graft function. The aim of this review is to discuss the key immunologic components of obliterative bronchiolitis, describe the state of establishing immune tolerance in transplantation, and highlight those strategies being evaluated in lung transplantation.

AB - Despite significant medical advances since the advent of lung transplantation, improvements in long-term survival have been largely unrealized. Chronic lung allograft dysfunction, in particular obliterative bronchiolitis, is the primary limiting factor. The predominant etiology of obliterative bronchiolitis involves the recipient's innate and adaptive immune response to the transplanted allograft. Current therapeutic strategies have failed to provide a definitive treatment paradigm to improve long-term outcomes. Inducing immune tolerance is an emerging therapeutic strategy that abrogates allograft rejection, avoids immunosuppression, and improves long-term graft function. The aim of this review is to discuss the key immunologic components of obliterative bronchiolitis, describe the state of establishing immune tolerance in transplantation, and highlight those strategies being evaluated in lung transplantation.

KW - Chronic lung allograft dysfunction

KW - Immune tolerance

KW - Obliterative bronchiolitis

KW - Transplant immunology

KW - Transplant tolerance

UR - http://www.scopus.com/inward/record.url?scp=84905084563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905084563&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2014.06.015

DO - 10.1016/j.humimm.2014.06.015

M3 - Article

VL - 75

SP - 887

EP - 894

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 8

ER -